WallStreetZenWallStreetZen

NASDAQ: KLRA
Kailera Therapeutics Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Kailera Therapeutics earnings were -$149.0M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest KLRA earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter.

KLRA earnings history

Current Revenue
$0.0
Current Earnings
-$149.0M
Current Profit Margin
0%

KLRA Return on Equity

Insufficient data to display

KLRA Return on Assets

Current Company
-34.2%
Current Industry
-9.6%

Be the first to know when KLRA announces earnings.

KLRA Return on Capital Employed

Current Company
-23.06%
Current Industry
-3.7%

KLRA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AAPGN/A-$180.11MN/A-$2.02
AARD-$57.18M-$57.59MN/A-$2.93
ABUS-$33.04M-$33.50MN/A-$0.17
ABVC-$6.96M-$7.91MN/A-$0.39
ABVX-$249.93M-$386.32MN/A-$5.55
View Top Biotech Stocks

Kailera Therapeutics Earnings Reports & History FAQ

What were Kailera Therapeutics's earnings last quarter?

Kailera Therapeutics (NASDAQ: KLRA) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total KLRA earnings for the quarter were N/A. In the same quarter last year, Kailera Therapeutics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Kailera Therapeutics stock.

Is Kailera Therapeutics profitable or losing money?

As of the last Kailera Therapeutics earnings report, Kailera Therapeutics is currently losing money. Kailera Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$148.96 million, a N/A decrease year over year.

What was KLRA's earnings growth in the past year?

As of Kailera Therapeutics's earnings date in Q2 2026, Kailera Therapeutics's earnings has grown year over year. KLRA earnings in the past year totalled -$148.96 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.